Original Article
International Journal of Obesity (2006) 30, 1545–1556. doi:10.1038/sj.ijo.0803283; published online 21 March 2006
Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial
R M Hackman1, P J Havel1, H J Schwartz2, J C Rutledge2, M R Watnik3, E M Noceti1, S J Stohs4, J S Stern1,2 and C L Keen1,2
- 1Department of Nutrition, University of California, Davis, CA, USA
- 2Department of Internal Medicine, University of California, Davis, CA, USA
- 3Department of Statistics, California State University, East Bay, CA, USA
- 4Department of Pharmacy Science, Creighton University, Omaha, USA
Correspondence: Dr RM Hackman, Department of Nutrition, University of California, One Shields Avenue, Davis, CA 95616-8669, USA. E-mail: rmhackman@ucdavis.edu
Received 24 June 2005; Revised 6 January 2006; Accepted 19 January 2006; Published online 21 March 2006.
Abstract
Objective:
To determine the safety and efficacy of a dietary supplement with a low dose of ephedra and caffeine in overweight/obese premenopausal female subjects.
Design:
A 9-month, double-blind, randomized control study compared the efficacy and safety of a dietary supplement with ephedra and caffeine to a control supplement.
Subjects:
Sixty-one healthy, premenopausal women with body mass index (BMI) from 27 to 39 kg/m2 were randomly assigned and received a dietary supplement (40 mg/day ephedra alkaloids, 100 mg/day caffeine, high potency mixture of vitamins, minerals, omega-3 fatty acids) or a control supplement for 9 months.
Measurements:
Efficacy: changes in body weight, body composition, lipids, insulin, leptin, adiponectin, ghrelin, and self-reports of physical activity, diet and quality of life indices. Safety: blood pressure, heart rate, electrocardiograms, urinalysis, blood histology, serum chemistry measures and self-reported symptoms.
Results:
Forty-one women completed the study. The treatment group lost significantly more body weight (-7.18 kg) and body fat (-5.33 kg) than the control group (-2.25 and -0.99 kg, respectively), and showed significant declines in heart rate, serum cholesterol, triglycerides, cholesterol to high-density lipoprotein ratio, glucose, fasting insulin, and leptin. Blood pressure, electrocardiograms, other clinical chemistry measures, blood histology, urinalysis, and self-reported physical activity were similar in the groups. Minor symptoms included dry mouth, insomnia, nervousness and palpitations. The treatment group reported more energy and decreased appetite compared to controls and scored higher on a quality of life domain assessing vitality.
Conclusion:
A dietary supplement containing a low potency ephedra/caffeine mixture appeared safe and effective in causing loss of weight and body fat, and improving several metabolic parameters, including insulin sensitivity and lipid profiles when tested under physician supervision. Such supplements could be a useful tool to assist with weight loss.
Keywords:
(MeSH) ephedra, weight loss, dietary supplement, lipids, insulin, leptin
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
International Journal of Obesity Original Article
International Journal of Obesity Letter
International Journal of Obesity Letter
Concerning ephedra alkaloids for weight loss
International Journal of Obesity Letter
